{"id":43108,"date":"2026-04-01T22:12:11","date_gmt":"2026-04-01T22:12:11","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/43108\/"},"modified":"2026-04-01T22:12:11","modified_gmt":"2026-04-01T22:12:11","slug":"redstone-leads-2m-pre-seed-for-zurich-neurotech-connectome-health-to-track-brain-changes-in-real-time-tfn","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/43108\/","title":{"rendered":"Redstone leads $2M pre-seed for Zurich neurotech Connectome Health to track brain changes in real time \u2014 TFN"},"content":{"rendered":"<p>One in three people will face a neurological condition in their lifetime, with over 70% of cognitive decline happening silently before diagnosis. <\/p>\n<p> While traditional cognitive tests like\u00a0Cambridge Brain Sciences\u00a0or\u00a0Lumosity\u00a0capture single moments,\u00a0Connectome Health, a Zurich neurotech startup, tracks brain activity repeatedly over time. The platform then builds personalised baselines that reveal subtle shifts early on from burnout, ADHD, or early dementia.<\/p>\n<p>Today,\u00a0Connectome Health has raised\u00a0a $2 million pre-seed round,\u00a0led by\u00a0<a href=\"https:\/\/techfundingnews.com\/simplifying-data-privacy-for-businesses-this-german-startup-picks-e4m-seed-funding-to-accelerate-growth\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Redstone<\/a>, with\u00a0<a href=\"https:\/\/techfundingnews.com\/concept-ventures-raises-88m-europes-largest-pre-seed-fund\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Concept Ventures<\/a>, <a href=\"https:\/\/techfundingnews.com\/octopus-2b-us-energy-transition-game-changer-london-vcs\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Octopus<\/a>, and transatlantic angels joining the round. The financing also includes\u00a0$120k non-dilutive public funding. <\/p>\n<p>Linking brain activity to everyday life<\/p>\n<p><a href=\"https:\/\/ch.linkedin.com\/in\/lucasscherdel\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Lucas Scherdel<\/a> and\u00a0<a href=\"https:\/\/www.linkedin.com\/in\/rufus-mitchell-heggs\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Dr Rufus Mitchell-Heggs<\/a>, both neuroscientists with personal experience of brain disorders, founded Connectome in 2024. Scherdel\u2019s career spans WHO global health programs and consumer R&amp;D; Mitchell-Heggs brings computational neuroscience from memory\/social cognition research.<\/p>\n<p>Their tech stems from Imperial College London\u2019s\u00a0LUCID study, proving that everyday behaviours leave unique, measurable signatures in brain blood flow, enabling real-world cognitive tracking beyond lab constraints.<\/p>\n<p>Unlike\u00a0Kernel\u00a0or\u00a0Muse\u00a0(hardware-focused) or\u00a0Cognixion\u00a0(AR neurotech), Connectome\u2019s edge is\u00a0contextual interpretation, linking neural signals to sleep, activity, and behavioural load. The platform shows\u00a0why\u00a0cognition changes, making brain health actionable for consumers and researchers without replacing clinical care by linking neural data to daily context (sleep, activity, behavioural load). <\/p>\n<p>The funding fuels product rollout with select partners and R&amp;D to expand beyond lifestyle\/wearables into broader diagnostics. <\/p>\n<p>\u201cCognitive capacity underpins how we think, work, relate, and age, yet it remains poorly understood. Evidence shows cognitive health is quietly deteriorating at scale, with rising burnout, brain fog, and attention and memory issues, especially among younger generations. Understanding the brain is no longer a niche concern \u2013 it is essential to human wellbeing and societal resilience,\u201d says Scherdel. <\/p>\n","protected":false},"excerpt":{"rendered":"One in three people will face a neurological condition in their lifetime, with over 70% of cognitive decline&hellip;\n","protected":false},"author":2,"featured_media":43109,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[197,1750,8157,1202,1751,51],"class_list":{"0":"post-43108","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-zurich","8":"tag-europe","9":"tag-funding","10":"tag-healthtech","11":"tag-news","12":"tag-startups","13":"tag-zurich"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116331750593659946","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/43108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=43108"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/43108\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/43109"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=43108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=43108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=43108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}